Table 6.
Success type | 6 months (N = 103) |
12 months (N = 100) |
Year 2 (N = 74) |
Year 3 (N = 37) |
---|---|---|---|---|
Complete success1 | ||||
≤21 mmHg | 83.5 | 70 | 70.3 | 64.9 |
≤21 mmHg and ≥25% IOP reduction3 | 43.7 | 48 | 48.6 | 43.2 |
≤18 mmHg | 70.9 | 64 | 62.2 | 59.5 |
≤18 mmHg and ≥25% IOP reduction3 | 41.7 | 47 | 47.3 | 43.2 |
≤15 mmHg | 52.4 | 51 | 54.1 | 56.8 |
≤15 mmHg and ≥25% IOP reduction3 | 36.9 | 40 | 44.6 | 40.5 |
Qualified success2 | ||||
≤21 mmHg | 92.2 | 93 | 95.9 | 94.6 |
≤21 mmHg and ≥25% IOP reduction3 | 48.5 | 57 | 68.9 | 48.6 |
≤18 mmHg | 77.7 | 80 | 83.8 | 78.4 |
≤18 mmHg and ≥25% IOP reduction3 | 45.6 | 54 | 66.2 | 45.9 |
≤15 mmHg | 56.3 | 62 | 74.3 | 67.6 |
≤15 mmHg and ≥25% IOP reduction3 | 39.8 | 46 | 63.5 | 43.2 |
1No use of antiglaucoma medication. 2Use of ≤2 (including 0) antiglaucoma medications. 3IOP reduction from baseline/pre-op measurement.